24_10_STREAM_SiteHeader_OP

2025 CDMO LEADERSHIP AWARDS CEREMONY

Now in its 14th year, the CDMO Leadership Awards, presented by Outsourced Pharma and brought to you by Life Science Connect with research by Orientation Marketing, highlight the industry’s most valued partners, as determined by the customers who use their services. This year’s awards ceremony introduced new categories and many new winners, based on enhanced scoring methodology, and a refined approach based on customer feedback.

Watch our on-demand broadcast of the event that took place on March 19th, 2025 at The POOL in New York City to share in the celebration of the best in the industry!

 

RECENT WEBINARS

42:30 GettyImages-2178829362-glp-1-protein-3d-render

Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery

38:12 Benefits Of Outsourcing To An Integrated CDMO

Benefits Of Outsourcing To An Integrated CDMO

27:00 pace extractable and leachable webinar thumb

Extractables, Leachables, And Risk: Ensuring Safety In Pharma Manufacturing

1:01:26 solving fragmentation web

Solving Fragmentation: Future-Proofing The Advanced Therapy Supply Chain

1:01:57 bendbioscience release formulation thumb

Strategic Approaches To Controlled Release Formulation: Polymer Screening And Case Study Insights

37:25 Scientists working in lab-GettyImages-542935478

Building Quality By Design For Multi-Specific Therapeutic Proteins

45:47 GettyImages-1405590436-lab-perfusion-cleanroom

N-1 Perfusion Strategies For Commercial-Ready Biologics

43:45 GettyImages-1061027852-adenovirus

Enabling CTA Submission In Record Time: Adenovirus Program Success

1:02:51 GettyImages-1807380795-analytics-cell-analysis-laboratory

Donor-To-Dose Solutions For Scalable Cell Therapy Manufacturing

1:09:30 How Compliance-Driven CDMOs Win Sponsor Contracts

How Compliance-Driven CDMOs Win Sponsor Contracts

1:12:53 450_300-screenshot_2025_08_06_103131

Process Intensification: Your Guide To "Doing More With Less"

32:44 GettyImages-1354171893 technology

Accelerated Tech Transfer With Integrated, Client-Focused Project Management

More Recent Webinars

SMALL MOLECULE OUTSOURCING

52:59 1_65AA665392E1671A0015AD9300B430F0

How To Safely Handle Your Antibody Drug Conjugate

24:37 Scientists Mixing Solution In Lab GettyImages-1443286944

Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

58:43 Scientist in lab GettyImages-872025342

From Powder To Particles With Jet Milling

1:00:00 alcami nitro web thumb

Understanding Nitrosamines: Key Regulations And Best Practices

4:02 Luigi Bellone

Cambrex Scientist Spotlight: Luigi Bellone

1:32 GettyImages-1153537012 patient

How Can Nanoparticle Engineering Make The Difference For Alzheimer's?

10:59 GettyImages-1425605790 Life Sciences Training. Scientists Using A Computer In A Lab

Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load

15:45 GettyImages-1074166486-brain-scan-results-radiologist-doctor

How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma

45:22 1_42C78B445EC0AB6C66A5ABE8052C828B

Local Delivery For Treatment Of Lung Cancer

1:00:36 GettyImages-1346675635-lab-tablet-research-team

Taste Masking 101: Sensory And Performance Evaluation

3:57 Elena Bejan

Cambrex Scientist Spotlight: Elena Bejan

4:49 Cambrex Scientist Spotlight

Cambrex Scientist Spotlight: Shawn Conway

More Small Molecule Outsourcing Videos
24_10_STREAM_Brand_Category_Banner_LONZA_top v2
52:59 1_65AA665392E1671A0015AD9300B430F0

How To Safely Handle Your Antibody Drug Conjugate

13:51 GettyImages-1346675522-lab-team-microscope-computer-collaboration

The CDMO Value Proposition For Your Autologous Cell Therapy

53:38 GettyImages-2017789595 lab, research

Early Preclinical Development: A Successful Transition To cGMP Manufacturing

24:37 Scientists Mixing Solution In Lab GettyImages-1443286944

Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

1:02:28 1

Early Development To Clinic – De-Risking A Bioconjugate's Journey

58:43 Scientist in lab GettyImages-872025342

From Powder To Particles With Jet Milling

31:15 GettyImages-1294339670-lab-cleanroom-PPE-computer-team

Keys To A Successful cGMP Manufacturing Operation Delivering CGTs

32:23 1_9CE82855B543B4966E969CE57B550278

DNA To IND In 11 Months: Integrated Drug Substance, Drug Product Offering

56:49 Getty Images-1245951271-compliance-regulation-quality

IND Submissions In China: What's Different From Other Regions?

45:22 1_42C78B445EC0AB6C66A5ABE8052C828B

Local Delivery For Treatment Of Lung Cancer

46:33 GettyImages-542935478-lab-development-research

Overcoming The Challenges In Fabs And Fc-Fusion Development Programs

58:29 GettyImages-598090516-lab

CMC Strategy To Take Bispecifics From DNA To IND In 13 Months

More Lonza Videos
24_10_STREAM_Brand_Category_Banner_LONZA_bottom v2

CELL AND GENE OUTSOURCING

43:20 GettyImages-1368429013-fill-finish-aseptic

Future-Proof Your Aseptic Filling

11:20 Northway

Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service

9:59 cryoport webinar thumb

Optimizing Viability And Standardization For Clinical Excellence

1:00:37 Cryport - webinar bucket

Critical Supply Chain And Logistics Considerations For Cell And Gene Therapy Management

13:51 GettyImages-1346675522-lab-team-microscope-computer-collaboration

The CDMO Value Proposition For Your Autologous Cell Therapy

53:38 GettyImages-2017789595 lab, research

Early Preclinical Development: A Successful Transition To cGMP Manufacturing

6:08 Get To Know WuXi Advanced Therapies Testing Services

Get To Know Minaris Advanced Therapies Testing Services

40:15 GettyImages-525440825-cleanroom-pipette-lab

Sustainable Approaches To Oligonucleotide Manufacturing

31:15 GettyImages-1294339670-lab-cleanroom-PPE-computer-team

Keys To A Successful cGMP Manufacturing Operation Delivering CGTs

48:56 Cell And Gene Therapy Development

Cell & Gene Therapy Development: Characterization Of Cellular Starting Material

57:46 Cell Lab GettyImages-1183901928

Scalable Suspension LVV Production Platforms

22:19 Lonza1

Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics

More Cell and Gene Outsourcing Videos

OUTSOURCED PHARMA CAPACITY UPDATE

25:35 OP Capacity Update

Upperton Pharma Solutions Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form

20:14 OP Capacity Update

Quotient Sciences Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form

22:46 OP Capacity Update

PCI Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form

20:30 OP Capacity Update

Your Boutique CDMO Partner Of Choice

21:58 OP Capacity Update

Comprehensive CDMO Services From Clinical To Commercial Supply

22:59 OP Capacity Update

MilliporeSigma Capacity Update July 2025: Small Molecule Drug Substance/API

22:01 OP Capacity Update

Amorphous Solid Dispersions: Pre-Clinical To Commercial Capabilities

21:09 OP Capacity Update

Your Integrated Drug Substance Partner

20:05 OP Capacity Update

Aragen Capacity Update July 2025: Small Molecule Drug Substance/API

18:17 OP Capacity Update

Resilience Capacity Update July 2025: Large Molecule Drug Substance

21:54 OP Capacity Update

Novartis Contract Manufacturing Capacity Update July 2025: Large Molecule Drug Substance

22:07 OP Capacity Update

Providing Development And Supply Of Life-Changing Medicines

Outsourced Pharma Capacity Update Page

BIOLOGIC OUTSOURCING

11:20 Northway

Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service

21:33 abzena october opcu

Abzena Capacity Update October 2024: ADC

13:18 abzena cc AbZelectPRO thumb

The Next-Gen Cell Line Development Platform Fueling Biologics Success

1:39 Aji OPTIMA 7000

OPTIMA 7000 Fill Line

1:43 GettyImages-1297146235-dna

Providing Value Optimized, Time Saving Oligo Solutions

23:33 fuji safety thumb

Building A Strong Safety Culture In The Biopharmaceutical Industry

1:09 GettyImages-1444551560-filling-aseptic-fill-finish-line

Handle Your Drug Product With The Highest Quality And Safety

0:44 Meeting Needs And Exceeding Expectations Worldwide

Meeting Needs And Exceeding Expectations Worldwide

1:35 Ampoule Aseptic Filling GettyImages-1490244818

Delivering Top Quality Fill Finish Manufacturing

1:32 GettyImages-2036497686-lab-team-collaboration-laboratory-tablet-computer

Discovering A Unique Multimillion Euro Nanotechnology Facility

1:19 Expertise In Commercial Fill-Finish For More Than 30 Years

Expertise In Commercial Fill-Finish For More Than 30 Years

1:52 iStock-879831370-plasmid-lab-cell

Rising To Meet Increasing Demand For Microbial Based Biologics

More Biologic Outsourcing Videos

OUTSOURCED PHARMA LIVE

1:01:45 What If You Need Multiple CDMO Partnerships? (A Discussion On Resilience And Risk Mitigation)

What If You Need Multiple CDMO Partnerships? (A Discussion On Resilience And Risk Mitigation)

4:57 25_06_OPL_1280x720_Seg11

The World Outside Influencing Your Outsourcing Internals

2:06 25_06_OPL_1280x720_Seg10

Creating Your ADC Supply Chain

4:02 25_06_OPL_1280x720_Seg06

Your CDMO Knows A Lot - Are You Listening?

4:39 25_06_OPL_1280x720_Seg03

CDMO SOWs Must (Re-)Align With New Project Realities

5:31 25_06_OPL_1280x720_Seg09

It's Not What You Deserve, It's What You Negotiate

4:48 25_06_OPL_1280x720_Seg04

Budgeting Key Component In Biologics Flexibility At CDMOs

1:30 25_06_OPL_1280x720_Seg02

An Intro To CDMO Flexibility

2:27 25_06_OPL_1280x720_Seg01

Outsourcing Biologics Comes With "Demands"

1:40 25_06_OPL_1280x720_Seg05

Negotiating With Your CDMOs

3:47 25_06_OPL_1280x720_Seg08

Here's Where CDMOs Improve For Cell And Gene Therapy Customers?

2:38 25_06_OPL_1280x720_Seg07

Are You Asking For Unrealistic Flexibility At Your CDMO?

Outsourced Pharma Live Page

OUTSOURCING FUNDAMENTALS

0:30 GettyImages-1413600685-lab-team-collaboration-computer-research

Visionary Thinkers And Problem Solvers: The Cambrex Team

0:30 GettyImages-1146473276-team-collaboration-partnership-discussion

Fostering CDMO Collaboration On Both Sides

4:23 Catalent-DTP

Understanding Options In Direct-To-Patient Clinical Supply

2:42 Map global Logistics GettyImages-1202209630

Commercial Drug Sourcing For Clinical Trials

1:13 23_10_OPL_Challenges_Webinar_Seg01

Workforce Challenges Key To Outsourcing

1:35 Ampoule Aseptic Filling GettyImages-1490244818

Delivering Top Quality Fill Finish Manufacturing

0:30 Scientist in lab GettyImages-872025342

Collaborating To Craft Efficient Processes

2:33 GettyImages-171136123-japan

The Ultimate Guide To Clinical Supplies For Japan Studies

4:15 23_10_OPL_Challenges_Webinar_Seg02

Managing Multiple Partners – And Materials – From Around The Globe

2:54 China Globe World

Global Advantage With Free Trade Zones In China

More Outsourcing Fundamentals Videos

BUSINESS OF BIOTECH

57:54 Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

1:04:36 Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

52:07 BoB_1280x720_Vladimir_Cmiljanovic

Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.

52:37 Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

58:11 How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

52:03 The Generalist Biotech CEO With Seekyo's Oury Chetboun

The Generalist Biotech CEO With Seekyo's Oury Chetboun

54:07 BoB_1280x720_Ebrahim_Delpassand

Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

45:41 BoB_1280x720_Ep263

Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.

54:23 24_01_BoB_1280x720_Ep262

The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics

32:40 24_01_BoB_1280x720_Ep261

BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies

56:34 24_01_BoB_1280x720_Ep260

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

1:04:33 24_01_BoB_1280x720_Ep259

FDA Trials And Tribulations With Connect Biopharma's Barry Quart

58:23 24_01_BoB_1280x720_Ep258_2

Proactive Procurement Strategies For Biotech With Tom Wells

1:06:27 24_01_BoB_1280x720_Ep257

The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson

55:50 24_01_BoB_1280x720_Ep256

Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.

56:27 24_01_BoB_1280x720_Ep255

Biotech Angel Investing With Yaniv Sneor

59:23 24_01_BoB_1280x720_Ep254

Leading A tRNA Startup With Alltrna's Michelle Werner

39:45 24_01_BoB_1280x720_Ep253

Executing A Product Pivot With Vir's Mark Eisner, MD

55:54 24_01_BoB_1280x720_Ep252

Commercializing RNAi Therapies With Alnylam's Tolga Tanguler

55:45 24_01_BoB_1280x720_Ep251

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

46:08 24_01_BoB_1280x720_Ep250

The Implications Of China's Growing Biotech Industry With Allan Shaw

44:20 24_01_BoB_1280x720_Ep249

How To Be A CFO With Insmed's Sara Bonstein

46:43 24_01_BoB_1280x720_Ep248

Deal And Investment Trends With Investment Banker David Sans

34:44 24_01_BoB_1280x720_Ep247

Business of Biotech 2.0 with Ben Comer

43:32 24_01_BoB_1280x720_Ep246

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

43:46 24_01_BoB_1280x720_Ep245

BoB@JPM: Kasper Roet, Ph.D., QurAlis

52:20 24_01_BoB_1280x720_Ep244

BoB@JPM: Rick Modi, Affinia Therapeutics

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

47:59 24_01_BoB_1280x720_Ep242

BoB@JPM: Tom Chalberg, Ph.D., Genascence

37:00 24_01_BoB_1280x720_Ep241

BoB@JPM: Ran Zheng, Landmark Bio

45:07 24_01_BoB_1280x720_Ep240

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

43:00 24_01_BoB_1280x720_Ep239

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

47:50 24_01_BoB_1280x720_Ep238

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

1:13:36 24_01_BoB_1280x720_Ep237

High-Throughput Discovery With BIOPTIC's Andrey Dobry

1:06:32 24_01_BoB_1280x720_Ep236

RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.

54:04 24_01_BoB_1280x720_Ep235

Biotech Story Time With Tal Zaks, M.D. (Part 2)

1:02:34 24_01_BoB_1280x720_Ep234

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

55:25 24_01_BoB_1280x720_Ep233

Biotech Story Time With Tal Zaks, M.D. (Part 1)

52:50 24_01_BoB_1280x720_Ep232

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

1:03:50 24_01_BoB_1280x720_Ep231

Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski

45:26 24_01_BoB_1280x720_Ep230

Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.

49:54 24_01_BoB_1280x720_Ep229

Biopolitics With Allan Shaw

1:01:35 24_01_BoB_1280x720_Ep228

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

46:48 24_01_BoB_1280x720_Ep227

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

49:12 24_01_BoB_1280x720_Ep226

An Unanticipated Biotech Startup With OS Therapies' Paul Romness

44:14 24_01_BoB_1280x720_Ep225

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

51:34 24_01_BoB_1280x720_Ep223

Biotech C-Suite Construction With Allan Shaw

59:19 24_01_BoB_1280x720_Ep222

The Peptide Promise With NervGen's Mike Kelly

1:17:16 24_01_BoB_1280x720_Ep221

Biotech Course Correction With Treehill Partners' Ali Pashazadeh

1:14:26 24_01_BoB_1280x720_Ep220

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

54:05 24_01_BoB_1280x720_Ep218

Embracing Biotech Chaos With Memo's Erik van den Berg

1:04:47 24_01_BoB_1280x720_Ep217

Pivoting To RNA With Circio's Dr. Erik Digman Wiklund

1:03:07 24_01_BoB_1280x720_Ep216

mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

59:37 24_01_BoB_1280x720_Ep214

Leading From Within with ISCT & Kiji's Miguel Forte, M.D.

56:38 24_01_BoB_1280x720_Ep212

Expanding The Proteome with ProFound's John Lepore, M.D.

1:06:39 24_01_BoB_1280x720_Ep211

From The Bench To The Boardroom with ImmunityBio's Enrique Diloné

1:08:52 24_01_BoB_1280x720_Ep210

First AI Antibody In Humans with Aulos' Aron Knickerbocker

1:12:31 24_01_BoB_1280x720_Ep209

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

58:06 24_01_BoB_1280x720_Ep208

Topical Ocular Biologics with Claris Bio's Clarke Atwell

1:04:08 24_01_BoB_1280x720_Ep206

True DEI Value in Biopharma with Arcellx's Rami Elghandour

22:57 BoB_Ep204_Ch02

How Daiichi Sankyo Revitalized ADCs

55:45 24_01_BoB_1280x720_Ep205

Mission-Driven Dementia Funding with DDF's Jonathan Behr

26:07 BoB_Ep203_Ch02

How Is Mythic Therapeutics Transforming The ADC Space?

1:04:06 24_01_BoB_1280x720_Ep204

ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller

56:38 24_01_BoB_1280x720_Ep203

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

12:15 BoB_Ep196_Ch04

What's Next For Ampersand Biomedicines?

12:15 BoB_Ep196_Ch03

Marrying Computational Biology To Biotech Science

14:15 BoB_Ep196_Ch02

How Can ML And AI Improve Drug Development Success Rates?

13:55 BoB_Ep196_Ch01

Jason Gardner: From GSK To Ampersand Biomedicines CEO

22:42 BoB_Ep198_Ch03

Best Practices To Building And Funding A Successful CRISPR-Based Company

18:15 BoB_Ep198_Ch02

Ups And Downs Of The Biotech Industry

19:20 BoB_Ep198_Ch01

How Tome Biosciences' Rahul Kakkar Balances Medical Practice, Biotech Leadership, and Venture Capital Advising

7:52 BoB_Ep199_Ch02

How Orna Pioneered Circular RNA Drug Development

22:18 BoB_Ep199_Ch04

What Are The Challenges To Running An RNA Biotech?

17:19 BoB_Ep199_Ch03

What Are The Advantages Of Circular RNA?

11:25 BoB_Ep199_Ch01

How Orna Therapeutics' Tom Barnes Got Into RNA Drug Development

57:35 24_01_BoB_1280x720_Ep202

The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch

11:10 BoB_Ep200_Ch03

What's Next For Anima Biotech?

30:10 BoB_Ep200_Ch02

How Can AI Revolutionize Biotech?

17:18 BoB_Ep200_Ch01

Amina Biotech's Yochi Slonim On Tech-Enabled Drug Discovery

10:12 BoB_Ep201_Ch03_2

How Can Biotech Industry Leaders Build Public Trust?

8:29 BoB_Ep201_Ch02_2

Will Direct-To-Consumer Options Solve The Drug Price Problem?

21:00 BoB_Ep201_Ch01

Why Does The Pharmaceutical Supply Chain's Last Mile Have Broken Links?

59:10 24_01_BoB_1280x720_Ep200

New Apps For AI in mRNA With Anima Biotech's Yochi Slonim

59:11 24_01_BoB_1280x720_Ep199

Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch

1:01:30 24_01_BoB_1280x720_Ep198

Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.

56:54 24_01_BoB_1280x720_Ep197

Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.

49:47 24_01_BoB_1280x720_Ep196

Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, Ph.D.

40:16 24_01_BoB_1280x720_Ep195

Funding Alzheimer's Tx Dev with ADDF's Karen Harris

1:13:54 24_01_BoB_1280x720_Ep194

The AI Impact with Generate:Biomedicines' Mike Nally

47:52 24_01_BoB_1280x720_Ep193

Strategic Deals With CinRx's Gavin Samuels, M.D.

31:32 24_01_BoB_1280x720_Ep192

Serial Success With Triumvira's Rob Williamson

50:43 24_01_BoB_1280x720_Ep191_2

The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.

40:38 24_01_BoB_1280x720_Ep190

Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.

51:07 24_01_BoB_1280x720_Ep189

Managing Mergers With Sail's Guillaume Pfefer, Ph.D

45:51 24_01_BoB_1280x720_Ep188

Reprogramming Human Cells With bit.bio's Mark Kotter, M.D.

46:59 24_01_BoB_1280x720_Ep187

Inhalable mRNA With Ethris' Carsten Rudolph, Ph.D.

51:02 24_01_BoB_1280x720_Ep186

Biotech Is Back With Allan Shaw

Business of Biotech Page

CELL & GENE PODCAST

20:58 Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease with Ernexa Therapeutics' Sanjeev Luther

Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease with Ernexa Therapeutics' Sanjeev Luther

23:15 What Changes to FDA and CBER Mean for the Future of CGT with Daniela Drago

What Changes to FDA and CBER Mean for the Future of CGT with Daniela Drago

20:16 Inside CRISPR-GPT with Yuanhao Qu

Inside CRISPR-GPT With Yuanhao Qu

45:40 Barriers, Breakthroughs, and Building Access in Pediatric CGTs with Bambi Grilley, Ph.D.

Barriers, Breakthroughs, and Building Access in Pediatric CGTs with Bambi Grilley, Ph.D.

38:30 Defining Product Roles and Navigating FDA Approval with Monika Swietlicka

Defining Product Roles and Navigating FDA Approval with Monika Swietlicka

24:15 25_08_Cell&GeneThePodcast_1280x720_Ep109

Advancing Gene Therapy for FTD with Passage Bio's Dr. Will Chou

47:14 FDA Fridays: Advancing Communication and Consistency in CGT Regulation with Kaye Spratt

FDA Fridays: Advancing Communication and Consistency in CGT Regulation with Kaye Spratt

33:17 Navigating the Journey to Safer Stem Cell Therapies with Orca Bio's Nate Fernhoff

Navigating The Journey To Safer Stem Cell Therapies With Orca Bio's Nate Fernhoff

24:52 25_07_C&GPodcat_EP107_1280x720

Rethinking Large Animal Models in Gene Therapy with Novartis' Ralf Schmid, Ph.D.

20:13 23_12_CGPodcast_1280x720_Ep106

Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath

15:58 23_12_CGPodcast_1280x720_Ep105

Extracellular Vesicle Breakthroughs with Aegle Therapeutics' Dr. Gloria Matthews

24:46 23_12_CGPodcast_1280x720_Ep104

Bridging Development and Regulation in CGT with Halloran Consulting Group's Monika Swietlicka

More Cell & Gene Podcast Videos

MOST RECENT OUTSOURCED PHARMA LIVE VIDEO

1:01:45 What If You Need Multiple CDMO Partnerships? (A Discussion On Resilience And Risk Mitigation)
What If You Need Multiple CDMO Partnerships? (A Discussion On Resilience And Risk Mitigation)

As if outsourcing development and manufacturing wasn’t difficult enough, how does a biopharma organization (of any size) handle a multi-CDMO coordination? Sure, most talk today is about simplifying supply chains. But the need for redundancy, risk management, and fin...